{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:05:22Z","timestamp":1759482322976,"version":"3.40.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,22]]},"DOI":"10.7759\/cureus.80996","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T15:24:44Z","timestamp":1742657084000},"source":"Crossref","is-referenced-by-count":1,"title":["Clear Cell Sarcoma of the Knee: A Case Report of Diagnostic Challenges, Rapid Metastatic Spread, and Treatment Dilemmas"],"prefix":"10.7759","author":[{"given":"Abid Nawaz Khan","family":"Adil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakht","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed S","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2014.01.016","article-title":"Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli","volume":"40","author":"Bianchi G","year":"2014","unstructured":"Bianchi G, Charoenlap C, Cocchi S, et al.. Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli. Eur J Surg Oncol. 2014, 40:505-10. 10.1016\/j.ejso.2014.01.016","journal-title":"Eur J Surg Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.940927","article-title":"Case report: robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy","volume":"10","author":"Sidlik Muskatel R","year":"2022","unstructured":"Sidlik Muskatel R, Pillar N, Godefroy J, Lotem M, Goldstein G. Case report: robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy. Front Pediatr. 2022, 10:940927. 10.3389\/fped.2022.940927","journal-title":"Front Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196509)18:9<1163::aid-cncr2820180916>3.0.co;2-0","article-title":"Clear\u2010cell sarcoma of tendons and aponeuroses. An analysis of 21 cases","volume":"18","author":"Enzinger FM","year":"1965","unstructured":"Enzinger FM. Clear\u2010cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer. 1965, 18:1163-74. 10.1002\/1097-0142(196509)18:9&lt;1163::aid-cncr2820180916&gt;3.0.co;2-0","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198307000-00003","article-title":"Malignant melanoma of soft parts. A reassessment of clear cell sarcoma","volume":"7","author":"Chung EB","year":"1983","unstructured":"Chung EB, Enzinger FM. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol. 1983, 7:405-13. 10.1097\/00000478-198307000-00003","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/984096","article-title":"Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases","volume":"2012","author":"Hocar O","year":"2012","unstructured":"Hocar O, Le Cesne A, Berissi S, et al.. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract. 2012, 2012:984096. 10.1155\/2012\/984096","journal-title":"Dermatol Res Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10404","article-title":"Molecular genetic characterization of the EWS\/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses","volume":"99","author":"Panagopoulos I","year":"2002","unstructured":"Panagopoulos I, Mertens F, D\u00eabiec-Rychter M, et al.. Molecular genetic characterization of the EWS\/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer. 2002, 99:560-7. 10.1002\/ijc.10404","journal-title":"Int J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199212000-00006","article-title":"Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases","volume":"16","author":"Lucas DR","year":"1992","unstructured":"Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol. 1992, 16:1197-204. 10.1097\/00000478-199212000-00006","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.916705","article-title":"Prognostic factors for survival in patients with clear cell sarcoma: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database","volume":"25","author":"Li AB","year":"2019","unstructured":"Li AB, Jiang BJ, Wang HH, Yang YS, Zhang XB, Lan GH, Shu WB. Prognostic factors for survival in patients with clear cell sarcoma: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Med Sci Monit. 2019, 25:6950-6. 10.12659\/MSM.916705","journal-title":"Med Sci Monit"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<969::AID-CNCR11>3.0.CO;2-Z","article-title":"Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases","volume":"86","author":"Deenik W","year":"1999","unstructured":"Deenik W, Mooi WJ, Rutgers EJ, Peterse JL, Hart AA, Kroon BB. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer. 1999, 86:969-75.","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2007.10.006","article-title":"Clear cell sarcoma (melanoma of soft parts): the Royal Marsden Hospital experience","volume":"34","author":"Clark MA","year":"2008","unstructured":"Clark MA, Johnson MB, Thway K, Fisher C, Thomas JM, Hayes AJ. Clear cell sarcoma (melanoma of soft parts): the Royal Marsden Hospital experience. Eur J Surg Oncol. 2008, 34:800-4. 10.1016\/j.ejso.2007.10.006","journal-title":"Eur J Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9502-7","article-title":"Chemotherapy in clear cell sarcoma","volume":"28","author":"Jones RL","year":"2011","unstructured":"Jones RL, Constantinidou A, Thway K, et al.. Chemotherapy in clear cell sarcoma. Med Oncol. 2011, 28:859-63. 10.1007\/s12032-010-9502-7","journal-title":"Med Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001561","article-title":"Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib\/II trial","volume":"8","author":"Martin-Broto J","year":"2020","unstructured":"Martin-Broto J, Hindi N, Grignani G, et al.. Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib\/II trial. J Immunother Cancer. 2020, 8:e001561. 10.1136\/jitc-2020-001561","journal-title":"J Immunother Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2480","article-title":"Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft-tissue sarcomas","volume":"28","author":"O'Sullivan Coyne G","year":"2022","unstructured":"O'Sullivan Coyne G, Kummar S, Hu J, et al.. Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft-tissue sarcomas. Clin Cancer Res. 2022, 28:279-88. 10.1158\/1078-0432.CCR-21-2480","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000644","article-title":"Cabozantinib as an emerging treatment for sarcoma","volume":"32","author":"Sch\u00f6ffski P","year":"2020","unstructured":"Sch\u00f6ffski P, Blay JY, Ray-Coquard I. Cabozantinib as an emerging treatment for sarcoma. Curr Opin Oncol. 2020, 32:321-31. 10.1097\/CCO.0000000000000644","journal-title":"Curr Opin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11719","article-title":"Superficial clear cell sarcoma (melanoma of soft parts) of the large toe in an 80-year-old female with a rare cytogenetic translocation","volume":"12","author":"Zambrano R","year":"2020","unstructured":"Zambrano R, Moesch J, Davis ER, Heaphy MR Jr, Miller R. Superficial clear cell sarcoma (melanoma of soft parts) of the large toe in an 80-year-old female with a rare cytogenetic translocation. Cureus. 2020, 12:e11719. 10.7759\/cureus.11719","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12694","article-title":"Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis","volume":"41","author":"Belum VR","year":"2016","unstructured":"Belum VR, Serna-Tamayo C, Wu S, Lacouture ME. Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis. Clin Exp Dermatol. 2016, 41:8-15. 10.1111\/ced.12694","journal-title":"Clin Exp Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40804","article-title":"Considerations for pain assessments in cancer patients: a narrative review of the Latin American perspective","volume":"15","author":"Pergolizzi J Jr","year":"2023","unstructured":"Pergolizzi J Jr, LeQuang JA, Coluzzi F, Magnusson P, Lara-Solares A, Varrassi G. Considerations for pain assessments in cancer patients: a narrative review of the Latin American perspective. Cureus. 2023, 15:e40804. 10.7759\/cureus.40804","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-024-01305-8","article-title":"Oral neuropathy associated with commonly used chemotherapeutic agents: a narrative review","volume":"28","author":"Kouri M","year":"2024","unstructured":"Kouri M, Rekatsina M, Vadalouca A, Viswanath O, Varrassi G. Oral neuropathy associated with commonly used chemotherapeutic agents: a narrative review. Curr Pain Headache Rep. 2024, 28:1209-17. 10.1007\/s11916-024-01305-8","journal-title":"Curr Pain Headache Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154374","article-title":"The usefulness of virtual reality in symptom management during chemotherapy in lung cancer patients: a quasi-experimental study","volume":"13","author":"Mitello L","year":"2024","unstructured":"Mitello L, Marti F, Mauro L, et al.. The usefulness of virtual reality in symptom management during chemotherapy in lung cancer patients: a quasi-experimental study. J Clin Med. 2024, 13:4374. 10.3390\/jcm13154374","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353303-clear-cell-sarcoma-of-the-knee-a-case-report-of-diagnostic-challenges-rapid-metastatic-spread-and-treatment-dilemmas","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T15:24:47Z","timestamp":1742657087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353303-clear-cell-sarcoma-of-the-knee-a-case-report-of-diagnostic-challenges-rapid-metastatic-spread-and-treatment-dilemmas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.80996","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,22]]}}}